Wolfgang Nickl - Bayer AG CFO, Member of the Management Board
BAYZF Stock | USD 20.64 0.18 0.88% |
CFO
Mr. Wolfgang U. Nickl was Chief Financial Officer, Member of the Management Board of Bayer Aktiengesellschaft since June 1, 2018. He was Member of the Management Board at the Company since April 26, 2018. He completed a Bachelor of Business Administration at the University of Cooperative Education Stuttgart in 1992 and obtained a MBA from the Marshall School of Business at the University of Southern California in Los Angeles, United States, in 2005. Starting in 1992, he acquired his first professional experience as a consultant and controller for German IT service provider SerCon. In 1995, he joined Western Digital Corporationrationration, San Jose, California, a manufacturer of hard disk drives and other data storage products. His first roles at this company were as Business Planning Manager in the Netherlands and then as Director Business Solutions in the United States. In 2000, Mr. Nickl was appointed Chief Financial Officer at IT company Converge in the United States. Two years later, he returned to Western Digital where he held a number of finance positions with increasing responsibility. He also headed World Business Operations at this company for a number of years before being promoted to Chief Financial Officer in 2010. In December 2013, Mr. Nickl joined ASML N.V. in the Netherlands as Executive Vice President and Chief Financial Officer. since 2018.
Age | 54 |
Tenure | 6 years |
Professional Marks | MBA |
Phone | 49 214 30 1 |
Web | https://www.bayer.com |
Bayer AG Management Efficiency
The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.13 %, meaning that it generated $0.13 on every $100 dollars invested by stockholders. Bayer AG's management efficiency ratios could be used to measure how well Bayer AG manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 4 records | CFO Age | ||
David CPA | Titan International | 56 | |
Neal CPA | Kaiser Aluminum | 65 | |
Kelly Steckelberg | Zoom Video Communications | 56 | |
Thomas CPA | Iridium Communications | 66 |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0576 |
Bayer AG Leadership Team
Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sarena Lin, Labor Officer | ||
Oliver Maier, Head Relations | ||
Gabriel Harnier, Patents Law | ||
Heiko Schipper, Member of the Management Board, Head of the Consumer Health Division | ||
Rodrigo Santos, Member Division | ||
Michael Preuss, Gov Communications | ||
Stefan Oelrich, Member of the Management Board, Head of the Pharmaceuticals Division | ||
Wolfgang Nickl, CFO, Member of the Management Board | ||
BerndPeter Bier, Head Taxes | ||
Werner Baumann, Chief Strategy and Portfolio Officer and Member of Management Board |
Bayer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bayer AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0576 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 87.41 B | |||
Shares Outstanding | 982.42 M | |||
Shares Owned By Institutions | 47.11 % | |||
Price To Earning | 321.83 X | |||
Price To Book | 1.36 X | |||
Price To Sales | 1.06 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Pink Sheet
Bayer AG financial ratios help investors to determine whether Bayer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.